Cargando…
A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda
Evolutionary theory hypothesizes that intermediate virulence maximizes pathogen fitness as a result of a trade-off between virulence and transmission, but empirical evidence remains scarce. We bridge this gap using data from a large and long-standing HIV-1 prospective cohort, in Uganda. We use an ep...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115872/ https://www.ncbi.nlm.nih.gov/pubmed/27815945 http://dx.doi.org/10.7554/eLife.20492 |
_version_ | 1782468588811059200 |
---|---|
author | Blanquart, François Grabowski, Mary Kate Herbeck, Joshua Nalugoda, Fred Serwadda, David Eller, Michael A Robb, Merlin L Gray, Ronald Kigozi, Godfrey Laeyendecker, Oliver Lythgoe, Katrina A Nakigozi, Gertrude Quinn, Thomas C Reynolds, Steven J Wawer, Maria J Fraser, Christophe |
author_facet | Blanquart, François Grabowski, Mary Kate Herbeck, Joshua Nalugoda, Fred Serwadda, David Eller, Michael A Robb, Merlin L Gray, Ronald Kigozi, Godfrey Laeyendecker, Oliver Lythgoe, Katrina A Nakigozi, Gertrude Quinn, Thomas C Reynolds, Steven J Wawer, Maria J Fraser, Christophe |
author_sort | Blanquart, François |
collection | PubMed |
description | Evolutionary theory hypothesizes that intermediate virulence maximizes pathogen fitness as a result of a trade-off between virulence and transmission, but empirical evidence remains scarce. We bridge this gap using data from a large and long-standing HIV-1 prospective cohort, in Uganda. We use an epidemiological-evolutionary model parameterised with this data to derive evolutionary predictions based on analysis and detailed individual-based simulations. We robustly predict stabilising selection towards a low level of virulence, and rapid attenuation of the virus. Accordingly, set-point viral load, the most common measure of virulence, has declined in the last 20 years. Our model also predicts that subtype A is slowly outcompeting subtype D, with both subtypes becoming less virulent, as observed in the data. Reduction of set-point viral loads should have resulted in a 20% reduction in incidence, and a three years extension of untreated asymptomatic infection, increasing opportunities for timely treatment of infected individuals. DOI: http://dx.doi.org/10.7554/eLife.20492.001 |
format | Online Article Text |
id | pubmed-5115872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-51158722016-11-28 A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda Blanquart, François Grabowski, Mary Kate Herbeck, Joshua Nalugoda, Fred Serwadda, David Eller, Michael A Robb, Merlin L Gray, Ronald Kigozi, Godfrey Laeyendecker, Oliver Lythgoe, Katrina A Nakigozi, Gertrude Quinn, Thomas C Reynolds, Steven J Wawer, Maria J Fraser, Christophe eLife Epidemiology and Global Health Evolutionary theory hypothesizes that intermediate virulence maximizes pathogen fitness as a result of a trade-off between virulence and transmission, but empirical evidence remains scarce. We bridge this gap using data from a large and long-standing HIV-1 prospective cohort, in Uganda. We use an epidemiological-evolutionary model parameterised with this data to derive evolutionary predictions based on analysis and detailed individual-based simulations. We robustly predict stabilising selection towards a low level of virulence, and rapid attenuation of the virus. Accordingly, set-point viral load, the most common measure of virulence, has declined in the last 20 years. Our model also predicts that subtype A is slowly outcompeting subtype D, with both subtypes becoming less virulent, as observed in the data. Reduction of set-point viral loads should have resulted in a 20% reduction in incidence, and a three years extension of untreated asymptomatic infection, increasing opportunities for timely treatment of infected individuals. DOI: http://dx.doi.org/10.7554/eLife.20492.001 eLife Sciences Publications, Ltd 2016-11-05 /pmc/articles/PMC5115872/ /pubmed/27815945 http://dx.doi.org/10.7554/eLife.20492 Text en © 2016, Blanquart et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Epidemiology and Global Health Blanquart, François Grabowski, Mary Kate Herbeck, Joshua Nalugoda, Fred Serwadda, David Eller, Michael A Robb, Merlin L Gray, Ronald Kigozi, Godfrey Laeyendecker, Oliver Lythgoe, Katrina A Nakigozi, Gertrude Quinn, Thomas C Reynolds, Steven J Wawer, Maria J Fraser, Christophe A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda |
title | A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda |
title_full | A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda |
title_fullStr | A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda |
title_full_unstemmed | A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda |
title_short | A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda |
title_sort | transmission-virulence evolutionary trade-off explains attenuation of hiv-1 in uganda |
topic | Epidemiology and Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115872/ https://www.ncbi.nlm.nih.gov/pubmed/27815945 http://dx.doi.org/10.7554/eLife.20492 |
work_keys_str_mv | AT blanquartfrancois atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT grabowskimarykate atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT herbeckjoshua atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT nalugodafred atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT serwaddadavid atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT ellermichaela atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT robbmerlinl atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT grayronald atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT kigozigodfrey atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT laeyendeckeroliver atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT lythgoekatrinaa atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT nakigozigertrude atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT quinnthomasc atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT reynoldsstevenj atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT wawermariaj atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT fraserchristophe atransmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT blanquartfrancois transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT grabowskimarykate transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT herbeckjoshua transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT nalugodafred transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT serwaddadavid transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT ellermichaela transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT robbmerlinl transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT grayronald transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT kigozigodfrey transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT laeyendeckeroliver transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT lythgoekatrinaa transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT nakigozigertrude transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT quinnthomasc transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT reynoldsstevenj transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT wawermariaj transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda AT fraserchristophe transmissionvirulenceevolutionarytradeoffexplainsattenuationofhiv1inuganda |